106 related articles for article (PubMed ID: 1311820)
41. Natriuretic peptides, but not nitric oxide donors, elevate levels of cytosolic guanosine 3',5'-cyclic monophosphate in ependymal cells ex vivo.
Wellard J; DeVente J; Hamprecht B; Verleysdonk S
Neurosci Lett; 2006 Jan; 392(3):187-92. PubMed ID: 16278044
[TBL] [Abstract][Full Text] [Related]
42. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Yamamoto K; Ikeda U; Shimada K
J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
[TBL] [Abstract][Full Text] [Related]
43. Effects of isatin on atrial natriuretic peptide-mediated accumulation of cGMP and guanylyl cyclase activity of PC12 cells.
Medvede AE; Abakumova OYu ; Podobed OV; Tsvetkova TA; Sandler M; Glover V
Life Sci; 2001 Aug; 69(15):1783-90. PubMed ID: 11665840
[TBL] [Abstract][Full Text] [Related]
44. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
45. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells.
Klinger JR; Warburton R; Carino GP; Murray J; Murphy C; Napier M; Harrington EO
Exp Cell Res; 2006 Feb; 312(4):401-10. PubMed ID: 16360149
[TBL] [Abstract][Full Text] [Related]
46. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages.
Kiemer AK; Hartung T; Vollmar AM
J Immunol; 2000 Jul; 165(1):175-81. PubMed ID: 10861050
[TBL] [Abstract][Full Text] [Related]
47. HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors.
Morishita Y; Sano T; Kase H; Yamada K; Inagami T; Matsuda Y
Eur J Pharmacol; 1992 Mar; 225(3):203-7. PubMed ID: 1355444
[TBL] [Abstract][Full Text] [Related]
48. Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts.
Redondo J; Bishop JE; Wilkins MR
Br J Pharmacol; 1998 Aug; 124(7):1455-62. PubMed ID: 9723958
[TBL] [Abstract][Full Text] [Related]
49. Studies on the activation mechanisms of guanylyl cyclase by serotonin, probably through a novel subtype of serotonin receptor (5-HTGC).
Tohda M; Imaizumi R; Sekiya A; Itoh N; Nomura Y
Biol Pharm Bull; 1995 Aug; 18(8):1072-5. PubMed ID: 8535398
[TBL] [Abstract][Full Text] [Related]
50. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.
Kohno M; Yasunari K; Yokokawa K; Murakawa K; Horio T; Takeda T
J Clin Invest; 1991 Jun; 87(6):1999-2004. PubMed ID: 1645748
[TBL] [Abstract][Full Text] [Related]
51. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
52. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
53. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors.
Deschepper CF; Picard S
J Neurochem; 1994 May; 62(5):1974-82. PubMed ID: 7908948
[TBL] [Abstract][Full Text] [Related]
54. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
55. Atrial natriuretic peptides elevate cyclic GMP levels in primary cultures of rat ependymal cells.
Wellard J; Rapp M; Hamprecht B; Verleysdonk S
Neurochem Res; 2003 Feb; 28(2):225-33. PubMed ID: 12608696
[TBL] [Abstract][Full Text] [Related]
56. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
57. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
58. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.
Stevens TL; Wei CM; Aahrus LL; Heublein DM; Kinoshita M; Matsuda Y; Burnett JC
Hypertension; 1994 May; 23(5):613-8. PubMed ID: 8175170
[TBL] [Abstract][Full Text] [Related]
59. Steroidogenic effect of atrial natriuretic factor in isolated mouse Leydig cells is mediated by cyclic GMP.
Mukhopadhyay AK; Schumacher M; Leidenberger FA
Biochem J; 1986 Oct; 239(2):463-7. PubMed ID: 3028372
[TBL] [Abstract][Full Text] [Related]
60. Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide.
Kiemer AK; Vollmar AM
Immunol Cell Biol; 2001 Feb; 79(1):11-7. PubMed ID: 11168617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
